These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 14962294

  • 1. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP, Richards A, Cruz G, Copeman L, Dunnett SB, Barker RA.
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [Abstract] [Full Text] [Related]

  • 2. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
    Zhou CY, McInnes E, Copeman L, Langford G, Parsons N, Lancaster R, Richards A, Carrington C, Thompson S.
    Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
    [Abstract] [Full Text] [Related]

  • 3. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
    Murakami H, Nagashima H, Takahagi Y, Miyagawa S, Fujimura T, Toyomura K, Nakai R, Yamada M, Kurihara T, Shigehisa T, Okabe M, Seya T, Shirakura R, Kinoshita T.
    Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
    [Abstract] [Full Text] [Related]

  • 4. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL, Jones A, Norman S, Holmes CH.
    Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
    [Abstract] [Full Text] [Related]

  • 5. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A, Nakanishi I, Namiki M, Hara T, Matsumoto M, Ishibashi M, Okuyama A, Zaid D, Seya T.
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [Abstract] [Full Text] [Related]

  • 6. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP.
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [Abstract] [Full Text] [Related]

  • 7. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH, Simpson KL, Okada H, Okada N, Wainwright SD, Purcell DF, Houlihan JM.
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
    Shimo K, Mizuno M, Nasu J, Hiraoka S, Makidono C, Okazaki H, Yamamoto K, Okada H, Fujita T, Shiratori Y.
    J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
    [Abstract] [Full Text] [Related]

  • 10. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A, Blok VT, Haasnoot WH, Ensink NG, Daha MR, Fleuren GJ.
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [Abstract] [Full Text] [Related]

  • 11. Differential expression of the complement regulatory proteins in the human eye.
    Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ.
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3579-84. PubMed ID: 7505007
    [Abstract] [Full Text] [Related]

  • 12. High-level tissue specific expression of human CD59, MCP, and DAF proteins from genomic clones in transgenic mice.
    Oldham ER, Velardo MA, Platt JL, Logan JS, Diamond L.
    Transplant Proc; 1996 Apr; 28(2):693. PubMed ID: 8623349
    [No Abstract] [Full Text] [Related]

  • 13. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA, van Wieringen PA, van Es LA, Daha MR.
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M, Shiraishi M, Oshiro T, Taira K, Sugawa H, Nozato E, Nomura H, Nagamine M, Muto Y.
    Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
    [Abstract] [Full Text] [Related]

  • 15. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
    Seya T, Okada M, Hara T, Matsumoto M, Miyagawa S, Oshimura M.
    Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716
    [Abstract] [Full Text] [Related]

  • 16. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt JL.
    Transplantation; 1995 Apr 27; 59(8):1177-82. PubMed ID: 7537395
    [Abstract] [Full Text] [Related]

  • 17. The control of hyperacute rejection by genetic engineering of the donor species.
    White DJ, Cozzi E, Langford G, Oglesby T, Wang MW, Wright L, Wallwork J.
    Eye (Lond); 1995 Apr 27; 9 ( Pt 2)():185-9. PubMed ID: 7556715
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG, Spendlove I.
    Curr Opin Investig Drugs; 2001 Jul 27; 2(7):959-66. PubMed ID: 11757799
    [Abstract] [Full Text] [Related]

  • 20. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
    Venneker GT, van den Hoogen FH, Boerbooms AM, Bos JD, Asghar SS.
    Lab Invest; 1994 Jun 27; 70(6):830-5. PubMed ID: 7516986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.